✦ LIBER ✦

Discovery of a Highly Potent, Orally Active Mitosis/Angiogenesis Inhibitor R1530 for the Treatment of Solid Tumors

✍ Scribed by Liu, Jin-Jun; Higgins, Brian; Ju, Grace; Kolinsky, Kenneth; Luk, Kin-Chun; Packman, Kathryn; Pizzolato, Giacomo; Ren, Yi; Thakkar, Kshitij; Tovar, Christian; Zhang, Zhuming; Wovkulich, Peter M.

Book ID: 118278942
Publisher: American Chemical Society
Year: 2013
Tongue: English
Weight: 305 KB
Volume: 4
Category: Article
ISSN: 1948-5875
DOI: 10.1021/ml300351e

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery of a Potent, Selective, and Or

Discovery of a Potent, Selective, and Orally Active Proteasome Inhibitor for the Treatment of Cancer

✍ Dorsey, Bruce D.; Iqbal, Mohamed; Chatterjee, Sankar; Menta, Ernesto; Bernardini 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 161 KB

Discovery of a Potent, Selective, and Or

Discovery of a Potent, Selective, and Orally Active Human Epidermal Growth Factor Receptor-2 Sheddase Inhibitor for the Treatment of Cancer†

✍ Yao, Wenqing; Zhuo, Jincong; Burns, David M.; Xu, Meizhong; Zhang, Colin; Li, Yu 📂 Article 📅 2007 🏛 American Chemical Society 🌐 English ⚖ 79 KB

Discovery and Preclinical Profile of Sax

Discovery and Preclinical Profile of Saxagliptin (BMS-477118): A Highly Potent, Long-Acting, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

✍ Augeri, David J.; Robl, Jeffrey A.; Betebenner, David A.; Magnin, David R.; Khan 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 214 KB

Dasatinib: A potent SRC inhibitor in cli

Dasatinib: A potent SRC inhibitor in clinical development for the treatment of solid tumors

✍ John Araujo; Christopher Logothetis 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 345 KB

The discovery of potent, selective, and

The discovery of potent, selective, and orally active pyrazoloquinolines as PDE10A inhibitors for the treatment of Schizophrenia

✍ Ginny D. Ho; Shu-Wei Yang; Jennifer Smotryski; Ana Bercovici; Terry Nechuta; Eli 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 932 KB

Discovery of Raltegravir, a Potent, Sele

Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS Infection

✍ Summa, Vincenzo; Petrocchi, Alessia; Bonelli, Fabio; Crescenzi, Benedetta; Dongh 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 262 KB